JP2020514261A5 - - Google Patents

Download PDF

Info

Publication number
JP2020514261A5
JP2020514261A5 JP2019533172A JP2019533172A JP2020514261A5 JP 2020514261 A5 JP2020514261 A5 JP 2020514261A5 JP 2019533172 A JP2019533172 A JP 2019533172A JP 2019533172 A JP2019533172 A JP 2019533172A JP 2020514261 A5 JP2020514261 A5 JP 2020514261A5
Authority
JP
Japan
Prior art keywords
lysine
glycine
acetylsalicylic acid
solution
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019533172A
Other languages
English (en)
Japanese (ja)
Other versions
JP7012725B2 (ja
JP2020514261A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/084369 external-priority patent/WO2018115434A1/en
Publication of JP2020514261A publication Critical patent/JP2020514261A/ja
Publication of JP2020514261A5 publication Critical patent/JP2020514261A5/ja
Application granted granted Critical
Publication of JP7012725B2 publication Critical patent/JP7012725B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019533172A 2016-12-23 2017-12-22 アセチルサリチル酸リジン・グリシン粒子の改良された合成 Active JP7012725B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16206723 2016-12-23
EP16206723.5 2016-12-23
PCT/EP2017/084369 WO2018115434A1 (en) 2016-12-23 2017-12-22 Improved synthesis of lysine acetylsalicylate · glycine particles

Publications (3)

Publication Number Publication Date
JP2020514261A JP2020514261A (ja) 2020-05-21
JP2020514261A5 true JP2020514261A5 (enExample) 2021-01-28
JP7012725B2 JP7012725B2 (ja) 2022-01-28

Family

ID=57680128

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019533172A Active JP7012725B2 (ja) 2016-12-23 2017-12-22 アセチルサリチル酸リジン・グリシン粒子の改良された合成

Country Status (11)

Country Link
US (1) US10882811B2 (enExample)
EP (1) EP3558920B1 (enExample)
JP (1) JP7012725B2 (enExample)
CN (1) CN110114333B (enExample)
AU (1) AU2017383071B2 (enExample)
CA (1) CA3044137C (enExample)
DK (1) DK3558920T3 (enExample)
ES (1) ES2877856T3 (enExample)
PT (1) PT3558920T (enExample)
RU (1) RU2764573C2 (enExample)
WO (1) WO2018115434A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113105326A (zh) * 2021-03-24 2021-07-13 海南卓华制药有限公司 赖氨匹林的制备方法及应用
AU2023205426A1 (en) 2022-01-05 2024-06-13 Aspiair Gmbh Improved synthesis of lysine acetylsalicylate · glycine particles

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2101867A (en) 1934-08-18 1937-12-14 Clemmy O Miller Manufacture of water-soluble, storage-stable acetylsalicylic acid products
FR1295304A (fr) 1956-05-07 1962-06-08 Equilibre Biolog L Nouveau sel de l'acide acétyl-salicylique et son procédé de préparation
US3392195A (en) 1963-09-09 1968-07-09 Galat Alexander Amino acid derivatives
ES385222A1 (es) 1970-11-05 1973-04-01 Liade Sa Lab Procedimiento de obtencion de una sal soluble del acido a- cetil salicilico.
JPS5610110A (en) 1979-07-06 1981-02-02 Green Cross Corp:The Acetyl salicylate salt preparation for injection
US4446132A (en) 1982-03-11 1984-05-01 Dynatech Laboratories Incorporated Nontoxic aspirin composition
FR2611501B1 (fr) 1987-03-04 1991-12-06 Corbiere Jerome Nouvelles compositions pharmaceutiques pour la voie buccale a base d'acetylsalielylate de lysine et leur procede d'obtention
CN1043138C (zh) * 1992-05-22 1999-04-28 安徽省蚌埠安宝药厂 赖氨匹林的制造方法
DE10034802A1 (de) * 2000-07-18 2002-01-31 Bayer Ag Stabile Salze von O-Acetylsalicylsäure mit basischen Aminosäuren
DE10202019A1 (de) * 2002-01-18 2003-07-24 Bayer Ag Stabile Salze von o-Acetylsalicylsäure mit basischen Aminosäuren II
US20060166901A1 (en) 2005-01-03 2006-07-27 Yu Ruey J Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids
DE102005025283A1 (de) * 2005-06-02 2006-12-07 Bayer Healthcare Ag Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin
DE102005049293A1 (de) 2005-10-15 2007-04-26 Bayer Healthcare Ag Kombinationspräparate von Salzen oder o-Acetylsalicylsäure
DE102008004386A1 (de) 2008-01-14 2009-07-23 Activaero Gmbh Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen
FR2965261B1 (fr) * 2009-09-30 2012-10-26 Holis Technologies Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue par ce procede
FR2973370B1 (fr) 2011-03-29 2013-05-03 Holis Technologies Procede a faible cout pour la preparation d'un acide o-acetylsalicyclique et d'un acide amine basique
CN102503845A (zh) * 2011-09-28 2012-06-20 广州普星药业有限公司 一种dl-赖氨酸阿司匹林盐的制备方法及其应用
ITMI20121144A1 (it) 2012-06-28 2013-12-29 Dipharma Francis Srl Procedimento per la preparazione di un sale di un farmaco antinfiammatorio non steroideo
FR3021654B1 (fr) 2014-05-28 2016-06-24 Unither Pharmaceuticals Procede de preparation d'un sel d'acide acetylsalicylique et d'un acide amine basique
DK3393517T3 (da) * 2015-12-22 2021-11-01 Aspiair Gmbh Acetylsalicylsyre til anvendelse til behandling af moderat til alvorlig influenza

Similar Documents

Publication Publication Date Title
JP2017527549A5 (enExample)
JP2019011344A5 (enExample)
HRP20140752T1 (hr) Kristalni oblici 5-amino-2,3-dihidroftalazin-1,4-dion natrijeve soli, farmaceutski pripravci koji ih sadrže i postupak za njihovu proizvodnju
MY182905A (en) Process for preparing a titanium-containing zeolitic material having an mww framework structure
JPWO2011055796A1 (ja) ピロロキノリンキノンのフリー体
RU2016148241A (ru) Синтез комплекса цинка с лизином из хлорида цинка
WO2016089758A3 (en) Organo-1-oxa-4-azonium cyclohexane compounds
MX378591B (es) Intermedios para la sintesis de derivados de acido biliar, en particular, de acido obeticolico
JP2019504865A5 (enExample)
CN109134315A (zh) 一种卡巴匹林钙的制备方法和由此方法制备的卡巴匹林钙
CN103749508A (zh) 一种促进果树芽体萌发抽枝的乳剂配方
JP2015038184A5 (enExample)
AR081267A1 (es) Procedimiento de obtencion de la forma cristalina a del febuxostat
JP2014520848A5 (enExample)
RU2019115337A (ru) Улучщенный синтез частиц ацетилсалицилата лизина⋅ глицина
HRP20171707T1 (hr) Postupak proizvodnje rivaroksabana
JP2013063896A5 (ja) アルカリ金属ケイ酸塩の合成方法
RU2017142996A (ru) Натриевая соль ингибитора транспортера мочевой кислоты и его кристаллическая форма
HRP20191522T1 (hr) Kristalinični oblici s-acetil-glutationa, njihove priprave i upotrebe u farmaceutskim i nutraceutskim formulacijama
CN109641869A (zh) 来那度胺的晶型及其制备方法和用途
CN109641841A (zh) 一种羟尼酮的制备方法
RU2011114776A (ru) Этил 1,6-диарил-4-ароил-3-гидрокси-2-оксо-8-фенил-1,7-диазаспиро [4.4]нона-3,6,8-триен-9-карбоксилаты и способ их получения
RU2014112829A (ru) Способ получения микрокапсул аминокислот в альгинате натрия
JP2016534047A5 (enExample)
CN111918869A (zh) 甘草酸衍生物的结晶、其结晶组合物、药物组合物及用途